These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21731536)

  • 1. Generic Hockey-Stick Model for Estimating Benchmark Dose and Potency: Performance Relative to BMDS and Application to Anthraquinone.
    Bogen KT
    Dose Response; 2011; 9(2):182-208. PubMed ID: 21731536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Python BMDS: A Python interface library and web application for the canonical EPA dose-response modeling software.
    Pham LL; Watford S; Friedman KP; Wignall J; Shapiro AJ
    Reprod Toxicol; 2019 Dec; 90():102-108. PubMed ID: 31415808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of In Vivo Versus In Vitro Benchmark Doses (BMDs) Derived From Micronucleus Test Data: A Proof of Concept Study.
    Soeteman-Hernández LG; Fellows MD; Johnson GE; Slob W
    Toxicol Sci; 2015 Dec; 148(2):355-67. PubMed ID: 26443842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of subchronic toxicity data using the benchmark dose approach.
    Gephart LA; Salminen WF; Nicolich MJ; Pelekis M
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):37-59. PubMed ID: 11259178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response assessment for developmental toxicity. III. Statistical models.
    Allen BC; Kavlock RJ; Kimmel CA; Faustman EM
    Fundam Appl Toxicol; 1994 Nov; 23(4):496-509. PubMed ID: 7867901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of a benchmark dose in the presence or absence of hormesis using posterior averaging.
    Kim SB; Bartell SM; Gillen DL
    Risk Anal; 2015 Mar; 35(3):396-408. PubMed ID: 25384940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical modeling of the hormetic dose zone and the toxic potency completes the quantitative description of hormetic dose responses.
    Belz RG; Piepho HP
    Environ Toxicol Chem; 2015 May; 34(5):1169-77. PubMed ID: 25523646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.
    Davis JA; Gift JS; Zhao QJ
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):181-91. PubMed ID: 21034758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric Bayesian methods for benchmark dose estimation.
    Guha N; Roy A; Kopylev L; Fox J; Spassova M; White P
    Risk Anal; 2013 Sep; 33(9):1608-19. PubMed ID: 23339666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benchmark Dose Modeling of
    Guo X; Mei N
    Toxicol Res; 2018 Oct; 34(4):303-310. PubMed ID: 30370005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonparametric estimation of benchmark doses in environmental risk assessment.
    Piegorsch WW; Xiong H; Bhattacharya RN; Lin L
    Environmetrics; 2012 Dec; 23(8):717-728. PubMed ID: 23914133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmark dose analysis for Bacillus anthracis inhalation exposures in the nonhuman primate.
    Taft SC; Hines SA
    Risk Anal; 2012 Oct; 32(10):1750-68. PubMed ID: 22469218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information-theoretic model-averaged benchmark dose analysis in environmental risk assessment.
    Piegorsch WW; An L; Wickens AA; West RW; Peña EA; Wu W
    Environmetrics; 2013 May; 24(3):143-157. PubMed ID: 24039461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmark dose profiles for joint-action continuous data in quantitative risk assessment.
    Deutsch RC; Piegorsch WW
    Biom J; 2013 Sep; 55(5):741-54. PubMed ID: 23852573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.
    Shao K; Gift JS
    Risk Anal; 2014 Jan; 34(1):101-20. PubMed ID: 23758102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simulation study of the influence of study design on the estimation of benchmark doses for developmental toxicity.
    Kavlock RJ; Schmid JE; Setzer RW
    Risk Anal; 1996 Jun; 16(3):399-410. PubMed ID: 8693165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benchmark dose calculation for ordered categorical responses.
    Chen CC; Chen JJ
    Risk Anal; 2014 Aug; 34(8):1435-47. PubMed ID: 24444309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparation of anthraquinone used in the National Toxicology Program cancer bioassay was contaminated with the mutagen 9-nitroanthracene.
    Butterworth BE; Mathre OB; Ballinger K
    Mutagenesis; 2001 Mar; 16(2):169-77. PubMed ID: 11230561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.